USPTO Can't Dodge Exela Suit Over Patent Revival
A Virginia federal judge on Wednesday preserved Exela Pharma Sciences LLC's lawsuit alleging the federal government improperly revived a patent related to injectable acetaminophen treatment Ofirmev, a significant victory as the...To view the full article, register now.
Already a subscriber? Click here to view full article